Founded in 2005, Korea Institute for Pharmaceutical Policy Affairs, KIPPA, is a non-profit, public foundation, approved by the Korean Ministry of Health and Welfare. The institute is contributed by three relevant parties, the Korean Pharmaceutical Association (KPA), the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KBPMA), and the Korea Pharmaceutical Distribution Association (KPDA).

KIPPA is a leading research center, which aims to promote public health through the development of policy regarding the rational use of medicines, pharmacy education, pharmacy practice, pharmaceutical industry, and pharmaceutical supply and distribution. In particular, we begin to develop ¡®a community pharmacy model as a health promotion center for community members¡¯. We are collecting and analysing big data accordingly to develop pharmacy-based policies, which pursue maximised pharmacy practice for all the Koreans.

In consequence, KIPPA will consistently implement research tailored to the promotion of health in the nation and worldwide. We kindly ask for supports from our fellow pharmacists, public and associations.

If you have any further enquiries about the institute or research in English, please contact us via e-mail (kippa.org@gmail.com).

Thank you.

Office Address
3FL, 194, Hyoryeong-ro, Seocho-gu, Seoul, Repbulic of Korea

ÇöÀçÀ§Ä¡ : Home : ¾Ë¸²¸¶´ç : °øÁö»çÇ×
   
¾Ë¸²¸¶´ç
°øÁö»çÇ×
º¸µµÀÚ·á
ÀÎÀçä¿ë
 
 
Á¦   ¸ñ [´ëÇѾà»çÀú³Î/ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ¸®Æ÷Æ®]ÀϺ», ¡®´Ü°ñ¾à»ç-ÀçÅù湮¿Ï·á¡¯ È£Æò ¼Ó Ȱ¼ºÈ­
³»   ¿ë

ÀϺ», ¡®´Ü°ñ¾à»ç-ÀçÅù湮¿Ï·á¡¯ È£Æò ¼Ó Ȱ¼ºÈ­

2020-01-11 22:28:00 ÇÑ»óÀÎ ±âÀÚ ÇÑ»óÀÎ ±âÀÚ hsicam@kpanews.co.kr

±¹³»¿Ü »ç·Ê°íÂûÀ» ÅëÇÑ Ä¿¹Â´ÏƼ Äɾ¼­ÀÇ Áö¿ª¾à±¹ ¹× ¾à»ç ¿ªÇҠŽ»ö2 

III. ÀϺ»ÀÇ Áö¿ªÆ÷°ýÄɾýºÅÛ°ú ¾à±¹¼­ºñ½º5)6) 
¡ÞÀϺ» Ä¿¹Â´ÏƼÄɾîÀÇ °³¿ä 
ÀϺ»Àº °í·ÉÈ­À² 26.6%·Î À̹̠Ãʰí·É»çȸ¸¦ °æÇèÇϰí ÀÖ´Ù. ÀÌó ·³ Ãʰí·É»çȸ ÁøÀÔ¿¡ ¸ÂÃç ÁַΠ65¼¼ ÀÌ»óÀÇ °í·ÉÀÚ¸¦ ´ë»óÀ¸·Î °í·É ÀÚÀÇ ÀÇ·á, °³È£, ¿¹¹æ, ÁÖ°Å, »ýȰ Áö¿ø ¼­ºñ½º¸¦ Á¦°øÇϴ Áö¿ª¹ÐÂøÇü ¼­ºñ½º ½Å¼³ ¹× Áö¿ªÆ÷°ýÄɾýºÅÛ ¸¶·ÃÀ» Çٽɠ¸ñÇ¥·Î Çϰí ÀÖ´Ù. Áï, È¯ÀÚÀÇ ¿ä¾çÀÌ ÀÌ·ç¾îÁö´Â Àå¼Ò¸¦ ÀÇ·á±â°üÀÌ ¾Æ´Ñ ÀçÅà¿ä¾ç½Ã¼³·Î ¿Å±â±â À§ÇØ ÀÇ·á¹ý, °³È£º¸Çè¹ý µîÀÇ ¹ý·ü Á¤ºñ¸¦ ÅëÇÑ Áö¿ªÆ÷°ýÄɾýºÅÛÀ» ±¸ÃàÇØ °í·ÉÀÚÀÇ »îÀÇ ÅÍÀüÀ» ±â¹ÝÀ¸·Î ÀÚ¸³»ýȰÀ» ÇÒ ¼ö ÀÖ µµ·Ï ÀÇ·á, ¿ä¾ç, ¿¹¹æ, °ÅÁÖ, »ýȰÁö¿ø¼­ºñ½º °ü°è ±â°ü°ú ¿¬°èÇØ Æ÷°ý ÀûÀ̰í Áö¼ÓÀûÀΠÀçÅàÀÇ·á½Ã½ºÅÛÀ» ÃßÁøÇϰí ÀÖ´Ù. ¶ÇÇÑ, ¾à»çµé¿¡°Ô µµ Áö¿ª Æ÷°ýÀûÀΠ¾à·á ¹× °Ç°­ÁõÁø¼­ºñ½º¸¦ Á¦°øÇϴ ¿ªÇÒÀ» ºÎ¿©ÇÏ °í À̸¦ È®´ëÇϱâ À§ÇÑ ³ë·ÂµéÀ» ¼öÇàÇϰí ÀÖ´Ù. 

¡ÞÁÖ¿ä Á¤Ã¥ ÃßÁø »óȲ 
ÀϺ»Àº 2013³â 8¿ù ÀÇ·á °³È£ ºÐ¾ßÀÇ °³ÇõÀ» Áß½ÉÀ¸·Î Çϴ »çȸº¸ ÀåÁ¦µµ°³Çõ ±¹¹ÎȸÀÇ º¸°í¼­¸¦ ¹ßÇ¥ÇßÀ¸¸ç, 2014³â 6¿ù ¡®Áö¿ªÀÇ·á ¹× °³È£ÀÇ Á¾ÇÕÀûÀΠȮº¸ÀÇ ÃËÁø¿¡ °üÇÑ ¹ý·ü(ÀǷᰳȣÁ¾ÇÕÈ®º¸ÃßÁø¹ý)¡¯ Á¦Á¤°ú ¡®°³È£º¸Çè¹ý¡¯ °³Á¤À» ÅëÇØ 2025³â ´ëºñÇÑ Áö¿ªÆ÷°ýÄɾýºÅÛ À» È®¸³Çسª°¡°í ÀÖ´Ù.7) Áö¿ªµ¹º½ ³×Æ®¿öÅ©´Â Áö¿ª¸¶´Ù ¹æ½ÄÀ̳ª ÃßÁø ¼Óµµ°¡ ´Ù¸£°í ¾ÆÁ÷ Á¤Ã¥´Ü°è¿¡ ÀÖÁö¸¸, ¼±µµ»ç¾÷À» ½ÃÇàÇϴ °¢ ÁöÀڠüº°·Î µ¹º½³×Æ®¿öÅ© ¸ðµ¨À» Á¦½ÃÇϴ µî ´Ù¾çÇÑ ¹æ½ÄÀ¸·Î ÃßÁøÀÌ ÀÌ ·ç¾îÁö°í ÀÖ´Ù.<±×¸²2 ÂüÁ¶> ÀÌ·¯ÇÑ ÀϺ»ÀÇ Áö¿ªÆ÷°ýÄɾýºÅÛÀ» µÑ ·¯½Ñ ³íÀï Áß Çϳª´Â °³È£º¸Çè °³ÆíÀÌ ³ëÀθ¸À» ´ë»óÀ¸·Î Çϰí À־¹ º½ÀÌ ÇÊ¿äÇÑ Àå¾ÖÀÎ, ¾Æµ¿À» Æ÷°ýÇÏÁö ¾Ê°í Àִٴ Á¡À¸·Î, 2016³â ÀÏ º» Á¤ºÎ°¡ Áö¿ª°ø»ý»çȸ¸¦ ¹ßÇ¥Çϸ鼭 Áö¿ªÆ÷°ýÄɾýºÅÛÀ» º¸´Ù º¸ ÆíÈ­Çϴ ¹æÇâ¿¡ ´ëÇÑ ³íÀïÀÌ ÁøÇà ÁßÀÌ´Ù. 

¡ÞÁö¿ªÆ÷°ýÄɾî ÇÁ·Î±×·¥ ±¸Ãà ¹× ¿î¿µ»ç·Ê 
ÀϺ»ÀÇ Áö¿ªÆ÷°ýÄɾî ÇÁ·Î±×·¥Àº Å©°Ô º¸°Ç(ÀÇ·á)°ú º¹Áö(¿ä¾ç)ÀÇ ¿¬ °è, Àç°¡ º¹±Í Áö¿øÀÇ °­È­, Áö¿ª»çȸ ³»¿¡¼­ÀÇ µ¹º½Ã¼°è°¡ ±¸ÃàµÉ ¼ö ÀÖµµ·Ï Çϴ Áö¿ªÈ¯°æ Á¶¼º°ú °ü·ÃµÅ ¿î¿µµÇ¾îÁ® ¿Ô´Ù. ÀϺ» µµ¾ß¸¶½Ã ¿¡¼­´Â ¸¶Ä¡³ªÄ« Á¾ÇÕÄɾ¾Å͸¦ ¼³¸³, Áö¿ª ³» Äɾºñ½º ÅëÇÕÁ¦°ø ¹× °ÅÁ¡ ÇãºêÈ­ ±â°üÀ¸·Î¼­ »êÈÄÄɾî, Áúº´º¸À°½Ç, ÀǷᰳȣ¿¬°è½Ç, Áø ·á¼Ò, º¸À°¿ø°ú °°Àº 5°¡ÁöÀÇ ¼­ºñ½º¸¦ Á¦°øÇϰí ÀÖ´Ù. ¶ÇÇÑ Ä¡¸Å¼ö±Þ ÀÚµéÀ» À§ÇѠƯº°¾çÈ£³ëÀÎȨ, ÁְŽü³°ú º¸°Ç½Ã¼³ÀÌ °áÇյȠÇüÅÂÀÇ °í·ÉÀÚ ÁÖÅÃÀΠī½Ã¿Í½Ã Åä¿ä½ÃŰ´ÙÀÌ ´ÜÁö µîÀÌ ±¸¼ºµÅ ÀÖ´Ù. º´¿ø¿¡ ¼­ Àç°¡·Î ¹Ù·Î º¹±ÍÇϱ⿡ ¾î·Á¿î »ç¶÷µéÀ» ´ë»óÀ¸·Î´Â ´Ü±â »ýȰÁö ¿ø°ú ÀÇ·á ¼­ºñ½º¸¦ Á¦°øÇϸç, °³È£³ëÀκ¸°Ç½Ã¼³ÀÌ ¿î¿µµÇ°í ÀÖ´Ù. ¼¼ Å¸°¡¾ß±¸ÀÇ °æ¿ì, Áö¿øÀ» ÇÊ¿ä·Î Çϴ ÁֹεéÀÇ ´Ù¾çÇÑ ¿å±¸¸¦ ÆÄ¾ÇÇÏ °í Àû¿ëÇϴ ¿ªÇÒÀ» Áö¿ªÆ÷°ýÁö¿ø¼¾ÅͿ͠»çȸº¹ÁöÇùÀÇȸ µîÀÌ ´ã´çÇÏ µµ·Ï ÇÔÀ¸·Î½á Áö¿ª °úÁ¦´Â Áö¿ªÀÇ ÈûÀ¸·Î ÇذáÇѴٴ ¸ñÇ¥ ´Þ¼ºÀ» À§ ÇÑ Àü·«Ã¼°è¸¦ ¸¶·ÃÇß´Ù. 
¶Ç ´Ù¸¥ Áö¿ªÆ÷°ýÄɾýºÅÛÀÇ ½Ç »ç·Ê º¸¸é8), µµÄìµµ ¿ÀŸ±¸ Áö¿ª ¿¡¼­ ±ä±Þ ¿¬¶ôó ¹× ÀÇ·áÁ¤º¸ µîÀ» Áö¿ªÆ÷°ýÁö¿ø¼¾ÅÍ¿¡ µî·ÏÇÑ °í·É ÀÚ¿¡°Ô µî·Ï¹øÈ£¿Í Áö¿ªÆ÷°ýÁö¿ø¼¾ÅÍÀÇ ÀüÈ­¹øÈ£°¡ ÀûÈù ¡®°í·ÉÀÚ ÁöÅ´ ÀÌ ¿­¼è°í¸®¡¯¸¦ ¹èÆ÷ÇØ ¸ö¿¡ Áö´Ï°Ô ÇÑ´Ù. 



¡Þ¾à±¹¿¡¼­ÀÇ ³ëÀÎÀ» À§ÇÑ ÀçÅú¸°ÇÀÇ·á ¼­ºñ½º 
±ÞÁõÇϴ ³ëÀÎÀα¸ÀÇ ÀûÀýÇÑ ¾à¹°º¹¿ë°ü¸®¸¦ ¾à±¹À» ÅëÇØ ´ã´çÇÏ°Ô ÇØ ºÒÇÊ¿äÇÑ ÀǾàǰ ºñ¿ë ¹× Ä¡·áºñ¿ëÀ» Àý°¨ÇÏÀڴ ÃëÁö¿¡¼­ 2016³â 4¿ù ºÎÅÍ ´Ü°ñ¾à»çÁ¦µµ°¡ ½ÃÇàµÇ°í ÀÖ´Ù. Áö¿ªÁֹεéÀº ´Ü°ñ¾à»ç ÀÎÁõÀ» ÀÌ ¼öÇÑ ¾à»çµé Áß ÀÚ½ÅÀÌ ¿øÇϴ ¾à»ç¸¦ ´Ü°ñ¾à»ç·Î µî·ÏÇØ ¼­ºñ½º¸¦ ¹ÞÀ» ¼ö ÀÖ´Ù. È¯ÀÚ ¶Ç´Â ÀϹݠ½Ã¹ÎµéÀ» ´ë»óÀ¸·Î °Ç°­ ¹× °³È£ º¸Çè¿¡ ´ëÇÑ »ó ´ãÀ» ÇØÁִ ¾à±¹, Áǰ­¼­Æ÷Æ® ¾à±¹(°Ç°­ °³È£ ±æ°Å¸® »ó´ã ¾à±¹)À» ¿î ¿µÇØ, ´Ù Á÷Á¾ °£ ¿¬°è¸¦ ÅëÇÑ ÀÇ·á, º¹Áö, °³È£, °Ç°­¿¡ °üÇÑ »ó´ãÀ» Á¦°ø ÇÑ´Ù. ¶ÇÇÑ, È¯ÀÚÀÇ °¡Á¤À̳ª ½Ã¼³À» ¹æ¹®ÇØ º¹¾àÁöµµ¼­ºñ½º¸¦ Æ÷ÇÔÇÑ ¿ä ¾çÁöµµ ¹× ÀǾàǰÀÇ ÇÕ¸®ÀûÀΠ»ç¿ë, ÀǾàǰ°ü¸®Áöµµ¸¦ ¼öÇàÇϴ ÀçÅà¹æ ¹®¾à·áÁ¦µµµµ ¾ð±ÞÇÒ ¼ö ÀÖ´Ù. ÀÌó·³ ÀϺ»¿¡¼­´Â ³ëÀÎÀ» À§ÇÑ ÀçÅÃÀÇ·á ÀÇ °³¼±À̶ó´Â ¸Æ¶ô¿¡¼­ È¯ÀÚµéÀÇ ¿ä±¸¿Í Á¤ºÎÀÇ ÀÇ·áºñ Àý°¨À̶ó´Â ÇÊ ¿ä¼ºÀÌ ¸Â¹°·Á ¾Õ¼­ ¼Ò°³ÇÑ Á¦µµµéÀ̠Ȱ¼ºÈ­µÅÁö°í ÀÖ´Ù.9) 

5) 2018³â ¡ºº¸°Ç»çȸ¿¬±¸¡» ÄÝ·ÎŰ¿ò Ä¿¹Â´ÏƼ Äɾî¿Í º¸°Çº¹Áö¼­ºñ½ºÀÇ ÀçÆí, Çѱ¹º¸°Ç»çȸ¿¬±¸¿ø, 2018 
6) Çؿܻç·Ê¿ÍÀÇ ºñ±³¸¦ ÅëÇÑ Çѱ¹Çü Ä¿¹Â´ÏƼ Äɾ³³äÁ¤¸³ ¹× ÃßÁø¹æÇâ, ¼­¿ï¿¬±¸¿ø, 2018 
7) À̴ ÀϺ»Á¤ºÎÀÇ °³Çõ¾È¿¡ µû¶ó ÃßÁø ÁßÀΠ°úÁ¦·Î ¾ÆÁ÷ ½ÃÇàµÇÁö ¾ÊÀº °Íµµ ¸¹´Ù. 
8) ±è¹ÌÁø(ÀϺ»(»ç)»ýȰ°æÁ¦Á¤Ã¥¿¬±¸¼Ò) (6/11/2017) ÀϺ» °í·É»çȸ¸¦ µÑ·¯½Ñ Áö¿ªÄ¿¹Â´ÏƼÀÇ ´ëÀÀ. Accessed 12/12/2019 https://50plus.or.kr/detail.do?id=45146 
9) ÀÇÇнŹ®, ¹æ¹®¾à·áÁ¦µµÈ­ ÇÊ¿äÇÏ´Ù, (4/4/2018), Accessed 12/12/2019 http://www.bosa.co.kr/ news/articleView.html?idxno=2080784 

<´ÙÀ½È£¿¡ °è¼Ó>


 

¹øÈ£ ÷ºÎ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏ Á¶È¸
168 û³â¾à»ç¿Í ¾à´ë»ýÀ» À§ÇÑ Ä¿¸®¾î °³¹ß °¡À̵åºÏ ÃÖÀ±Á¤ 2022-02-14 2793
167 2020³â ±âºÎ±Ý ¸ðÁý ¹× ÁöÃâ ¸í¼¼¼­ ÀÌÁö¿¬ 2021-05-10 1672
166 [ȯÀÚ¾ÈÀü º¸°íÇнÀ ½Ã½ºÅÛ] '¾à±¹ ¾àÁ¦¾÷¹« °ü¸®Áöħ ¾È³»' °Ô½Ã ±èÁøÀÌ 2020-06-25 3808
165 2021 ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ¿¬±¸¿ø ä¿ë °ø°í °ü¸®ÀÚ 2020-03-12 6951
164 [´ëÇѾà»çÀú³Î] ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ¸®Æ÷Æ®_Á¶±â´ëÀÀü°è¿¡ ÃÖÀûÈ­µÈ ¡®¾à±¹±â¹Ý °¨½Ã ½Ã½ºÅÛ¡¯ ±è¼±Èñ 2020-02-26 3676
163 [´ëÇѾà»çÀú³Î] ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ¸®Æ÷Æ®_Äڷγª19 ´ëÀÀ FIP ½Å±Ô °¡À̵å¶óÀÎ ±è¼±Èñ 2020-02-26 3255
162 [´ëÇѾà»çÀú³Î] ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ¸®Æ÷Æ®_¼¼°è ¾à±¹µéÀÇ °¨¿°¼º Áúȯ °¨½Ã ¹× ´ëÀÀ »ç·Ê ¼Ò°³ 1Æí ±è¼±Èñ 2020-02-12 2134
161 "¾à·á»ç¾÷ ³Ñ¾î Áö¿ª Á᫐ ¾à±¹ °Ç°­Çãºê ¿ªÇÒ Èû¾µ °Í" ±è¼±Èñ 2020-01-30 1751
160 "¾à±¹ '°Ç°­ÁõÁø Çãºê' ¹æÇâÀ¸·Î °¡¾ß"...·¹Áö½ºÆ®¸® ±¸Ãà º»°ÝÈ­ ±è¼±Èñ 2020-01-30 1548
159 [´ëÇѾà»çÀú³Î/ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ¸®Æ÷Æ®]¿µ±¹ ¾à±¹, °Ç°­ »ýȰ ¼¾ÅÍ·Î ¹ßµ¸¿ò ±è¼±Èñ 2020-01-30 1744
158 [´ëÇѾà»çÀú³Î/ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ¸®Æ÷Æ®]È£ÁÖ, ¹æ¹® ¾à·á µµÀÔÇØ ¾à¹° ¿ä¹ý ÇýÅà ±Ø´ëÈ­ ±è¼±Èñ 2020-01-30 1456
157 [´ëÇѾà»çÀú³Î/ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ¸®Æ÷Æ®]ÀϺ», ¡®´Ü°ñ¾à»ç-ÀçÅù湮¿Ï·á¡¯ È£Æò ¼Ó Ȱ¼ºÈ­ ±è¼±Èñ 2020-01-30 1543
156 [´ëÇѾà»çÀú³Î/ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò ¸®Æ÷Æ®]±¹³»¿Ü »ç·Ê°íÂûÀ» ÅëÇÑ Ä¿¹Â´ÏƼ Äɾ¼­ÀÇ Áö¿ª¾à±¹ ¹× ¾à»ç ¿ªÇÒ Å½»ö 1 ±è¼±Èñ 2020-01-30 1440
155 [±â»ç]ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò, ÆÐ³Î¾à±¹ ¸ðÁý Ȱµ¿ Àü°³ ±è¼±Èñ 2019-11-13 1609
154 [±â»ç]¾à±¹¸¸ÀÇ Ã¼°èÀû Á¤Ã¥¼ö¸³À§ÇÑ ¾à±¹DB ±¸Ãà 'ù¹ß' ±è¼±Èñ 2019-11-13 1515

ÀÌÀü 10ÆäÀÌÁö [1]  [2]  [3]  [4]  [5]  [6]  [7]  [8]  [9]  [10]  ´ÙÀ½ 10ÆäÀÌÁö

 
 

¼­¿ï ¼­Ãʱ¸ È¿·É·Î194, 3Ãþ (Àç)ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò TEL : 02) 3474-5301 / FAX : 02)3474-5306

COPYRIGHT (C) 2006 KOREA INSTITUTE FOR PHARMACEUTICAL POLICY AFFAIRS ALL RIGHTS RESERVED. FOR MORE INFORMATION MAL kippa.org@gmail.com

±âºÎ±Ý ¾È³»